英國醫界日前運用胚胎著床前基因篩選之技術，讓孕婦成功懷有不帶眼癌基因缺陷之寶寶，台大醫院在 2006 年 6 月 3 日亦發布其已發展出此一「胚胎基因篩選術」，將為患者「訂做」健康寶寶。未來諸如玻璃娃娃、海洋性貧血等單一基因缺陷也可望在「孕前」為基因篩選，訂做健康之下一代。因我國之人工生殖法草案延宕未決，相關基本原則及禁止規範付之闕如。一方面，就物種之生存而言，愈健康聰明者愈有生存競爭力，對於長期受不孕之苦，或者是帶有遺傳性疾病之家庭期望基因技術之發展能為其帶來一線生機無可厚非；但另一方面，胚胎基因篩選技術真如研究者所言準確率高，無安全性問題？又誰有資格決定那一個胚胎可以存活下來？依何種基準？此種代替上帝操作生死的事有無其法律上之界線？外國法例又是如何規範？凡此即是本論文要研究之重點。

Doctors applied the technology of preimplantation genetic diagnosis to help a woman have a health baby in England. In June 2006, National Taiwan University Hospital also announced it had developed such technology, which can produce health babies for parents. The special diseases such as Osteogenesis Imperfect, Thalassaemia－ the genetic defects can be found before birth. There is no relative principle or guideline in our country. Because the health creatures have competitiveness, the said technology brings parents hope. However, is there any danger of such technology? Who has the right to decide which embryo is worthless? What kind of standard should it be followed ? Is there any boundary in laws? What are the regulations in other countries? The questions above-mentioned are the points of the research.

傳基因篩選;基因診斷;生命倫理;生殖技術;遺傳諮詢

preimplantation genetic diagnosis;genetic test;biotic ethic;generate technology;genetic counseling